SC 13G Filing

Company

Esperion Therapeutics, Inc.

Filed

June 29, 2015

Accession Number

0001103804-15-000039

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →